Closed
SectorHealthcare
594.37 1.83
24h
Min
577.46
Max
594.92
Income | -109M 809M |
---|---|
Sales | -761M 3B |
P/E Sector Avg | 14.64 56.602 |
EPS | 8.22 |
Dividend yield | 0.67 |
Profit margin | 26.701 |
Employees | 15,158 |
EBITDA | -54M 1B |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +40.88% upside |
Dividend yield Sector Avg | 0.67% 2.45% |
---|---|
Next Earnings | 31 lip 2025 |
Market Cap | -13B 62B |
---|---|
Previous open | 592.54 |
Previous close | 594.37 |
By Acuity
36%
64%
122 / 382 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 804.95 USD 40.88%
High 979 USD
Low 535 USD
Based on 21 Wall Street analysts offering 12 month price targets forRegeneron Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$